Inhibition of p38 kinase using substituted heterocyclic ureas

1998 
(57) Abstract: The present invention is the use of a group of urea in the treatment of proteolytic enzymes mediated diseases other than cytokine-mediated diseases and cancer than cancer, and to pharmaceutical compositions for use in such treatment .
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []